An innovation award winning operational strategy expert and patient engagement thought leader with over 17 years in the NHS on commission by the DOH and in Industry (Hoffman La-Roche, Amgen, ALMAC, ICON and Biogen). Worked in England and Northern Ireland with temporary assignments in the USA (Pennsylvania, Texas and Massachusetts). Currently part of the DIA Patient Engagement Voluntary Community Leadership team.

Experience across various therapeutic areas such as Neurology, Inflammation, Metabolic Disease, Gastroenterology and Oncology across various phases of trials in drug development include creation and execution of successful strategies for research protocols and CRO oversight, patient and site feasibility, expertise in eClinical tools such as electronic Patient consent technologies, electronic clinical outcomes assessments and interactive response technologies, creation of optimal drug packaging and administration concepts, mapping the patient journey, planning and executing effective global site and patient engagement campaigns using direct to patient methods, leading and coaching remote and complex global teams.

Currently working as one of the Co-Leads for a cross-industry group with 7 other Bio-pharma companies to create an educational white paper on the use of Blockchain technology in clinical trials. Presented findings at Orlando at the Internet and Engineering Standards Forum (IEEE).